Sign in

Lung cancer trials, also abroad

2,747 open Lung cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
China1144
United States901
France316
Spain275
Italy272
All other countries

The same trial often runs in several countries

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) has 1 site in Costa Rica and runs in 30 countries. If a site near you is full, another one may still take people.

See A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) in all 30 countries